Anyone have any updates?
I haven't noticed much difference, although it has been less than two weeks so far.
I still haven't noticed anything in particular in the way of results.
From http://www.naturalnews.com/023177.html:
"...outstanding athletic performance, a significant reduction in muscle soreness and joint pain, radical improvements in resistance to UV sun exposure..."
outstanding athletic performance - haven't noticed any out-of-the-ordinary gains in the weight-lifting or spinning I do
a significant reduction in muscle soreness and joint pain - nope, I got plenty of both; haven't noticed that my knuckles or knees are any less sore than they usually are
radical improvements in resistance to UV sun exposure - nope; granted I have always burned easily, but 15 minutes of midday sun is enough to redden my skin, which happened to me this weekend when I stupidly didn't put on sunscreen until halftime at my kid's soccer game
I will not continue the high dose after my supply runs out, although I am thinking of keeping 4 mg/day in my regular regimen.
You probably are already but make sure you take each and every mg of Astaxanthin with some fat to maximise absorption...
http://www.sciencedi...577dc65223f7b88Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations
Johanna Mercke Odeberg, a, Åke Lignell, b, Annette Pettersson, b and Peter Höglund, , a
a Department of Clinical Pharmacology, Lund University Hospital, S-221 85, Lund, Sweden
b AstaCarotene AB, Gustavsberg, Sweden
Received 15 November 2002; revised 11 April 2003; accepted 30 April 2003. ; Available online 19 July 2003.
Abstract
Astaxanthin is a carotenoid with antioxidant properties, synthesised by plants and algae, and distributed in marine seafood.
Astaxanthin is also available as a food supplement, but, like other carotenoids, is a very lipophilic compound and has low oral bioavailability. However, bioavailability can be enhanced in the presence of fat. There is not much information in the literature about the pharmacokinetics of oral astaxanthin in humans. In this open parallel study, healthy male volunteers received a single dose of 40 mg astaxanthin, as lipid based formulations or as a commercially available food supplement, followed by blood sampling for further analysis of plasma concentrations. Pharmacokinetic parameters were calculated to evaluate the extent and rate of absorption from each formulation. The elimination half-life was 15.9±5.3 h (n=32), and showed a mono-phasic curve. Three lipid based formulations: long-chain triglyceride (palm oil) and polysorbate 80 (formulation A), glycerol mono- and dioleate and polysorbate 80 (formulation B), and glycerol mono- and dioleate, polysorbate 80 and sorbitan monooleate (formulation C), all showed enhanced bioavailability, ranging from 1.7 to 3.7 times that of the reference formulation. The highest bioavailability was observed with formulation B, containing a high content of the hydrophilic synthetic surfactant polysorbate 80.
Author Keywords: Astaxanthin; Pharmacokinetics; Lipid based formulations; Polysorbate 80; Bioavailability